These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 23474598

  • 1. Use of recombinant human bone morphogenetic protein-2 with local bone graft instead of iliac crest bone graft in posterolateral lumbar spine arthrodesis.
    Park DK, Kim SS, Thakur N, Boden SD.
    Spine (Phila Pa 1976); 2013 May 20; 38(12):E738-47. PubMed ID: 23474598
    [Abstract] [Full Text] [Related]

  • 2. Is lumbar facet fusion biomechanically equivalent to lumbar posterolateral onlay fusion?
    Toth JM, Foley KT, Wang M, Seim HB, Simon Turner A.
    J Neurosurg Spine; 2017 May 20; 26(5):586-593. PubMed ID: 28156207
    [Abstract] [Full Text] [Related]

  • 3. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH, Carreon LY, McGinnis MD, Campbell MJ, Glassman SD.
    Spine (Phila Pa 1976); 2009 Jun 01; 34(13):1390-4. PubMed ID: 19440166
    [Abstract] [Full Text] [Related]

  • 4. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age.
    Glassman SD, Carreon LY, Djurasovic M, Campbell MJ, Puno RM, Johnson JR, Dimar JR.
    Spine (Phila Pa 1976); 2008 Dec 15; 33(26):2843-9. PubMed ID: 19092613
    [Abstract] [Full Text] [Related]

  • 5. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years.
    Singh K, Smucker JD, Gill S, Boden SD.
    J Spinal Disord Tech; 2006 Aug 15; 19(6):416-23. PubMed ID: 16891977
    [Abstract] [Full Text] [Related]

  • 6. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
    Toth JM, Wang M, Lawson J, Badura JM, DuBose KB.
    J Neurosurg Spine; 2016 Dec 15; 25(6):733-739. PubMed ID: 27367941
    [Abstract] [Full Text] [Related]

  • 7. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW, Branch CL, Alexander JT, Burkus JK.
    Spine J; 2004 Dec 15; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR, Glassman SD, Burkus KJ, Carreon LY.
    Spine (Phila Pa 1976); 2006 Oct 15; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [Abstract] [Full Text] [Related]

  • 9. Posterolateral lumbar spine fusion with INFUSE bone graft.
    Glassman SD, Carreon L, Djurasovic M, Campbell MJ, Puno RM, Johnson JR, Dimar JR.
    Spine J; 2007 Oct 15; 7(1):44-9. PubMed ID: 17197332
    [Abstract] [Full Text] [Related]

  • 10. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
    Dimar JR, Glassman SD, Burkus JK, Pryor PW, Hardacker JW, Carreon LY.
    J Bone Joint Surg Am; 2009 Jun 15; 91(6):1377-86. PubMed ID: 19487515
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of rhBMP-2 versus iliac crest bone graft for posterior C1-C2 fusion in patients older than 60 years.
    Yan L, Chang Z, He B, Liu T, Wang X, Guo H, Hao D.
    Orthopedics; 2014 Jan 15; 37(1):e51-7. PubMed ID: 24683657
    [Abstract] [Full Text] [Related]

  • 12. The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion.
    Glassman SD, Carreon LY, Campbell MJ, Johnson JR, Puno RM, Djurasovic M, Dimar JR.
    Spine J; 2008 Jan 15; 8(3):443-8. PubMed ID: 17526436
    [Abstract] [Full Text] [Related]

  • 13. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion in patients over 60 years of age: a cost-utility study.
    Carreon LY, Glassman SD, Djurasovic M, Campbell MJ, Puno RM, Johnson JR, Dimar JR.
    Spine (Phila Pa 1976); 2009 Feb 01; 34(3):238-43. PubMed ID: 19179918
    [Abstract] [Full Text] [Related]

  • 14. Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion.
    Glassman SD, Dimar JR, Carreon LY, Campbell MJ, Puno RM, Johnson JR.
    Spine (Phila Pa 1976); 2005 Aug 01; 30(15):1694-8. PubMed ID: 16094268
    [Abstract] [Full Text] [Related]

  • 15. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial.
    Dawson E, Bae HW, Burkus JK, Stambough JL, Glassman SD.
    J Bone Joint Surg Am; 2009 Jul 01; 91(7):1604-13. PubMed ID: 19571082
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the use of rhBMP-7 versus iliac crest autograft in single-level lumbar fusion: a meta-analysis of randomized controlled trials.
    Ye F, Zeng Z, Wang J, Liu H, Wang H, Zheng Z.
    J Bone Miner Metab; 2018 Jan 01; 36(1):119-127. PubMed ID: 28342094
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL, Ogden K, Robertson IK, Broadhurst S, Edis D.
    Spine (Phila Pa 1976); 2014 Jan 15; 39(2):164-71. PubMed ID: 24153173
    [Abstract] [Full Text] [Related]

  • 18. Instrumented one and two level posterolateral fusions with recombinant human bone morphogenetic protein-2 and allograft: a computed tomography study.
    Stambough JL, Clouse EK, Stambough JB.
    Spine (Phila Pa 1976); 2010 Jan 01; 35(1):124-9. PubMed ID: 20042965
    [Abstract] [Full Text] [Related]

  • 19. Comparative Clinical Effectiveness and Safety of Bone Morphogenetic Protein Versus Autologous Iliac Crest Bone Graft in Lumbar Fusion: A Meta-analysis and Systematic Review.
    Liu S, Wang Y, Liang Z, Zhou M, Chen C.
    Spine (Phila Pa 1976); 2020 Jun 15; 45(12):E729-E741. PubMed ID: 31923133
    [Abstract] [Full Text] [Related]

  • 20. Bone union rate with recombinant human bone morphogenic protein-2 versus autologous iliac bone in PEEK cages for anterior lumbar interbody fusion.
    Flouzat-Lachaniette CH, Ghazanfari A, Bouthors C, Poignard A, Hernigou P, Allain J.
    Int Orthop; 2014 Sep 15; 38(9):2001-7. PubMed ID: 24627122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.